Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Am Med Dir Assoc ; 17(3): 276.e9-14, 2016 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-26805751

RESUMO

OBJECTIVES: This study investigated the overlap among 3 different definitions of potentially harmful medication (PHM) use and the corresponding associations with resident quality of life and mortality. DESIGN: Cross-sectional study with 3-year follow-up for mortality. SETTING: Assisted living facilities and nursing homes in Helsinki and Kouvola, Finland. PARTICIPANTS: A total of 326 residents. MEASUREMENTS: PHM use was defined as (1) use of medications with anticholinergic properties, (2) use of Beers Criteria medications, and (3) concomitant use 3 or more psychotropic medications. Health-related quality of life (HRQoL) was assessed using the 15D and psychological well-being (PWB) scale. Residents self-rated their own health using a 4-point scale. Mortality data were obtained from central registers. RESULTS: There were 38.0%, 28.2%, and 12.6% of residents who used PHMs according to 1 (G1), 2 (G2), and 3 definitions (G3), respectively. Overall, 21.2% of residents did not use PHMs according to any of the 3 definitions (G0). There were no significant differences in comorbidity, cognition, or functioning among groups. In adjusted analyses, there was a stepwise association between use of multiple PHMs and poorer self-rated health, poorer PWB, and poorer HRQoL. There was no association in adjusted analyses between PHM use and 3-year mortality (47.8%-63.8%). CONCLUSION: PHM use is highly prevalent in institutional settings, regardless of the definition of inappropriateness. Residents who used multiple categories of PHMs were at greatest risk of poor HRQoL, poor PWB, and poor self-rated health. However, there was no apparent association with increased mortality. Given the importance of quality of life as an outcome to older people, further efforts are needed to minimize PHM use in this setting.


Assuntos
Moradias Assistidas , Antagonistas Colinérgicos , Prescrição Inadequada , Mortalidade/tendências , Casas de Saúde , Psicotrópicos , Qualidade de Vida/psicologia , Idoso , Idoso de 80 Anos ou mais , Contraindicações , Estudos Transversais , Feminino , Finlândia/epidemiologia , Humanos , Masculino , Polifarmacologia , Sistema de Registros
2.
J Am Med Dir Assoc ; 15(12): 892-8, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24814043

RESUMO

OBJECTIVES: The objectives of this study were (1) to investigate the effect of nurse training on the use of potentially harmful medications; and (2) to explore the effect of nurse training on residents' health-related quality of life (HRQoL), health service utilization, and mortality. DESIGN: A randomized controlled trial. SETTING AND PARTICIPANTS: In total, 227 residents in 20 wards of assisted living facilities in Helsinki were recruited. The 20 wards were randomized into those in which (1) staff received two 4-hour training sessions on appropriate medication treatment (intervention group), and (2) staff received no additional training and continued to provide routine care (control group). INTERVENTION: Two 4-hour interactive training sessions for nursing staff based on constructive learning theory to recognize potentially harmful medications and corresponding adverse drug events. MEASUREMENTS: Use of potentially harmful medications, HRQoL assessed using the 15 dimensional instrument of health-related quality of life, health service utilization, and mortality assessed at baseline, and 6 and 12 months. RESULTS: During the 12-month follow-up, the mean number of potentially harmful medications decreased in the intervention wards [-0.43, 95% confidence interval (CI) -0.71 to -0.15] but remained constant in the control wards (+0.11, 95% CI -0.09 to +0.31) (P = .004, adjusted for age, sex, and comorbidities). HRQoL declined more slowly in the intervention wards (-0.038 (95% CI -0.054 to -0.022) than in the control wards (-0.072 (95% CI -0.089 to -0.055) (P = .005, adjusted for age, sex, and comorbidities). Residents of the intervention wards had significantly less hospital days (1.4 days/person/year, 95% CI 1.2-1.6) than in the control wards (2.3 days/person/year; 95% CI 2.1-2.7) (relative risk 0.60, 95% CI 0.49-0.75, P < .001, adjusted for age, sex, and comorbidities). CONCLUSIONS: Activating learning methods directed at nurses in charge of comprehensive care can reduce the use of harmful medications, maintain HRQoL, and reduce hospitalization in residents of assisted living facilities.


Assuntos
Moradias Assistidas , Prescrição Inadequada/prevenção & controle , Capacitação em Serviço , Recursos Humanos de Enfermagem/educação , Polimedicação , Idoso de 80 Anos ou mais , Causas de Morte , Feminino , Finlândia , Avaliação Geriátrica , Humanos , Masculino , Qualidade de Vida
3.
Trials ; 13: 85, 2012 Jun 18.
Artigo em Inglês | MEDLINE | ID: mdl-22709731

RESUMO

BACKGROUND: Use of inappropriate drugs is common among institutionalized older people. Rigorous trials investigating the effect of the education of staff in institutionalized settings on the harm related to older people's drug treatment are still scarce. The aim of this trial is to investigate whether training professionals in assisted living facilities reduces the use of inappropriate drugs among residents and has an effect on residents' quality of life and use of health services. METHODS AND DESIGN: During years 2011 and 2012, a sample of residents in assisted living facilities in Helsinki (approximately 212) will be recruited, having offered to participate in a trial aiming to reduce their harmful drugs. Their wards will be randomized into two arms: one, those in which staff will be trained in two half-day sessions, including case studies to identify inappropriate, anticholinergic and psychotropic drugs among their residents, and two, a control group with usual care procedures and delayed training. The intervention wards will have an appointed nurse who will be responsible for taking care of the medication of the residents on her ward, and taking any problems to the consulting doctor, who will be responsible for the overall care of the patient. The trial will last for twelve months, the assessment time points will be zero, six and twelve months. The primary outcomes will be the proportion of persons using inappropriate, anticholinergic, or more than two psychotropic drugs, and the change in the mean number of inappropriate, anticholinergic and psychotropic drugs among residents. Secondary endpoints will be, for example, the change in the mean number of drugs, the proportion of residents having significant drug-drug interactions, residents' health-related quality of life (HRQOL) according to the 15D instrument, cognition according to verbal fluency and clock-drawing tests and the use and cost of health services, especially hospitalizations. DISCUSSION: To our knowledge, this is the first large-scale randomized trial exploring whether relatively light intervention, that is, staff training, will have an effect on reducing harmful drugs and improving QOL among institutionalized older people. TRIAL REGISTRATION: ACTRN12611001078943.


Assuntos
Moradias Assistidas , Antagonistas Colinérgicos/uso terapêutico , Instituição de Longa Permanência para Idosos , Prescrição Inadequada/prevenção & controle , Capacitação em Serviço , Recursos Humanos de Enfermagem/educação , Psicotrópicos/uso terapêutico , Projetos de Pesquisa , Fatores Etários , Idoso , Moradias Assistidas/economia , Antagonistas Colinérgicos/efeitos adversos , Antagonistas Colinérgicos/economia , Protocolos Clínicos , Cognição/efeitos dos fármacos , Análise Custo-Benefício , Interações Medicamentosas , Finlândia , Avaliação Geriátrica , Custos de Cuidados de Saúde , Serviços de Saúde/economia , Serviços de Saúde/estatística & dados numéricos , Instituição de Longa Permanência para Idosos/economia , Humanos , Prescrição Inadequada/economia , Capacitação em Serviço/economia , Testes Neuropsicológicos , Recursos Humanos de Enfermagem/economia , Polimedicação , Psicotrópicos/efeitos adversos , Psicotrópicos/economia , Qualidade de Vida
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA